Invention Grant
- Patent Title: Methods and compositions for biomarkers of depression and pharmacoresponse
-
Application No.: US15509669Application Date: 2015-09-09
-
Publication No.: US10731216B2Publication Date: 2020-08-04
- Inventor: Sandra Ceccatelli , Dan Stefan Spulber
- Applicant: Sandra Ceccatelli , Dan Stefan Spulber
- Applicant Address: SE Solna
- Assignee: NORTHERNLIGHT DIAGNOSTICS AB
- Current Assignee: NORTHERNLIGHT DIAGNOSTICS AB
- Current Assignee Address: SE Solna
- Agency: Buchanan Ingersoll & Rooney P.C.
- International Application: PCT/EP2015/070644 WO 20150909
- International Announcement: WO2016/038107 WO 20160317
- Main IPC: C12Q1/6883
- IPC: C12Q1/6883 ; G16H50/20
Abstract:
The present invention relates to a method of diagnosing depression (even at an early stage that may precede clinical symptoms), for determining the pharmacoresponse to antidepressants, for managing treatment of psychiatric disorders, including depression, and for treatment of depression in patients. Further provided is a method for screening antidepressants.
Public/Granted literature
- US20180230536A1 METHODS AND COMPOSITIONS FOR BIOMARKERS OF DEPRESSION AND PHARMACORESPONSE Public/Granted day:2018-08-16
Information query
